If you or a loved one has health problems related to Reglan, you may be entitled to compensation. Fill out our convenient form
or call 1-800-217-1236 for nationwide reviews.
 Medical science and studies have shown a link between Tardive Dyskinesia, a serious and often irreversible movement disorder, and Reglan.
Tardive Dyskinesia, a syndrome consisting of potentially irreversible, involuntary body movements may develop in patients treated with Reglan (metoclopramide). Both the risk of developing the syndrome and the likelihood that it will become irreversible are believed to increase with the duration of treatment and the total cumulative dose.
The FDA has only approved Reglan for short term use (4 to 12 weeks), but approximately 30% of patients are being prescribed the medication for 12 months or longer, which can result in Tardive Dyskinesia
Although the labeling mentions Tardive Dyskinesia as a possible side effect, it claims the occurrence is rare. However, two studies have determined that 27 to 29 percent of long term users of Reglan come down with Tardive Dyskinesia.
Tardive Dyskinesia is a horrible, devastating syndrome that can last a lifetime. It affects victims physically and mentally. It cause involuntary movements of the tongue, mouth, face, lips and even arms and legs.
See News Section for just announced FDA warnings on Reglan.
Victim of Reglan?
For a free evaluation, fill out our convenient form
or call for nationwide reviews
1-800-217-1236
|
